Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 25, Number 3—March 2019
Historical Review

Tuberculosis Surveillance and Control, Puerto Rico, 1898–2015

Emilio Dirlikov1Comments to Author , Dana Thomas1Comments to Author , David Yost, Betzaida Tejada-Vera, Maria Bermudez, Olga Joglar, and Terence Chorba
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (E. Dirlikov, D. Thomas, D. Yost, O. Joglar, T. Chorba); United States Public Health Service, Commissioned Corps, Rockville, Maryland, USA (D. Thomas, D. Yost); National Center for Health Statistics, Hyattsville, Maryland, USA (B. Tejada-Vera); Puerto Rico Department of Health, San Juan, Puerto Rico (M. Bermudez, O. Joglar)

Main Article

Figure 1

Timeline of key TB control events in Puerto Rico (right) and developments in healthcare and politics (left), over 3 periods: 1898–1946, 1947–1992, and 1993–2015. BCG, bacillus Calmette-Guérin vaccine; CDC, US Centers for Disease Control and Prevention; DOT, directly observed therapy; La Reforma, Reforma de Salud de Puerto Rico; PAS, para-aminosalicylic acid; NTGS, National TB Genotyping Service; NTSS, National TB Surveillance System; PRDH, Puerto Rico Department of Health; PRERA, Puerto Rico Eme

Figure 1. Timeline of key TB control events in Puerto Rico (right) and developments in healthcare and politics (left), over 3 periods: 1898–1946, 1947–1992, and 1993–2015. BCG, bacillus Calmette-Guérin vaccine; CDC, US Centers for Disease Control and Prevention; DOT, directly observed therapy; La Reforma, Reforma de Salud de Puerto Rico; PAS, para-aminosalicylic acid; NTGS, National TB Genotyping Service; NTSS, National TB Surveillance System; PRDH, Puerto Rico Department of Health; PRERA, Puerto Rico Emergency Relief Administration; RVCT, report of verified case of tuberculosis; TB, tuberculosis; TB GIMS, TB Genotyping Information Management System; TST, tuberculin skin testing; USPHS, United States Public Health Service; Xpert MTB/RIF machine, multidrug/rifampin resistance machine (Cepheid, http://www.cepheid.com).

Main Article

1These authors were co–principal investigators.

Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external